FGL1 and malignant colon neoplasm: In MC38 colon cancer mouse models, the inhibition of FGL1 by anti-FGL1 mAb and the knockout of FGL1 in cancer cells result in a potent antitumor effect, and the proliferation of cancer cells is significantly inhibited [28].